½ÃÀ庸°í¼­
»óǰÄÚµå
1573035

°ñÀç»ý Àç·á ½ÃÀå : À¯Çü, Àç·á, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Àç·á ÇüÅÂ, Á¦Ç°º° - ¼¼°è ¿¹Ãø(2025-2030³â)

Bone Regeneration Material Market by Type (Bone Morphogenetic Proteins (BMPs), Cell-Based Matrices, Demineralized Bone Matrix (DBM)), Material (Ceramics, Composites, Polymer), Application, End User, Material Form, Product - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°ñÀç»ý Àç·á ½ÃÀåÀº 2023³â 56¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 60¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 7.72%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 94¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°ñÀç»ý Àç·á´Â °ñÀý, »À °á¼Õ, °ñ°Ý ÀÌ»ó°ú °°Àº Á¶°Ç¿¡¼­ »ÀÀÇ ÀÚ¿¬ Ä¡À¯ ¹× À缺Àå °úÁ¤À» Áö¿øÇÏ°í °­È­Çϵµ·Ï ¼³°èµÈ Ư¼ö Á¦Ç°ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Àç·áÀÇ Çʿ伺Àº Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, »À °ü·Ã Áúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ­, È¿°úÀûÀÎ °ñÀÌ½Ä ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â Ä¡°ú ¹× Á¤Çü¿Ü°ú ¼ö¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. Ä¡°ú ÀÓÇöõÆ®, ôÃß °íÁ¤, °üÀý Àç°Ç, ¿Ü»ó, Á¤Çü¿Ü°ú µî ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµÇ¸ç, º´¿ø°ú Ŭ¸®´Ð¿¡¼­ ¿¬±¸±â°ü¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ÃÖÁ¾»ç¿ëÀÚ¿¡°Ô ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº »ýüÀç·áÀÇ ±â¼ú ¹ßÀü, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÀÚ±Ý ¹× ÅõÀÚ Áõ°¡, ÇÕ¼º ¹× »ýüÀûÇÕ¼º Àç·áÀÇ Ã¤Åà Áõ°¡ µî ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ÀÎÇÁ¶ó¸¦ ÃËÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ ³ë·Â°ú À¯¸®ÇÑ »óȯ Á¤Ã¥Àº ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÖ÷´Ü ºñÁî´Ï½º ±âȸ´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç°ú Àç»ý ´É·ÂÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â »ýü Ȱ¼º Àç·á¿Í 3D ÇÁ¸°ÆÃ ½ºÄ³Æú´õÀÇ °³¹ß¿¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë, ±î´Ù·Î¿î ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÈ÷ ½ÅÈï Áö¿ª¿¡¼­ÀÇ ³·Àº ÀÎÁöµµ´Â ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ñÀ̽ÄÀç¿Í °ü·ÃµÈ ¸é¿ª ¹ÝÀÀ ¹× °¨¿° À§ÇèÀº ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¹°À» ±Øº¹Çϱâ À§ÇØ ±â¾÷Àº ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ °øÁ¤¿¡ ÃÊÁ¡À» ¸ÂÃß°í ±ÔÁ¦ °æ·Î¸¦ °£¼ÒÈ­ÇØ¾ß ÇÕ´Ï´Ù. Çõ½ÅÀûÀÎ ±â¼ú·Î´Â Àç·á Ư¼ºÀ» °³¼±ÇÏ°í ¿ì¼öÇÑ ±â°èÀû °­µµ¿Í »ý¹°ÇÐÀû Ȱ¼ºÀ» °¡Áø ´Ù±â´É¼º ½ºÄ³Æúµå¸¦ ¸¸µé±â À§ÇØ ³ª³ë±â¼ú¿¡ ÃÊÁ¡À» ¸ÂÃç¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ Çаè, »ê¾÷°è ¹× ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ Çù·ÂÇÏ¿© Á¶Á÷ °øÇÐÀÇ È¹±âÀûÀÎ ¹ßÀüÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. °ñÀç»ý Àç·á ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, ÀÌ·¯ÇÑ µµÀü ¼Ó¿¡¼­µµ ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í Àֱ⠶§¹®¿¡ »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇϰí Áö¼ÓÀûÀÎ ºñÁî´Ï½º ¼ºÀåÀ» À§ÇØ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ °­È­Çϱâ À§ÇÑ Àü·«Àû °èȹ°ú ±â¼úÀû ¼±°ßÁö¸íÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 56¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 60¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 94¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 7.72%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â °ñÀç»ý Àç·á ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°ñÀç»ý Àç·á ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ȯÀÚ¿Í ÀÇ·áÁø »çÀÌ¿¡¼­ ÷´Ü °ñÄ¡À¯ Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü
    • Çõ½ÅÀûÀÎ »ýü Àç·á¿Í ÇÕ¼º °ñÀÌ½Ä Á¦Ç°ÀÇ ÃâÇö
    • Á¦Ç° °³¹ßÀ» À§ÇÑ ¿¬±¸±â°ü ¹× ÁÖ¿ä »ê¾÷ü¿ÍÀÇ °øµ¿ ¿¬±¸
    • ÀÇ·áºñ ÁöÃâ Áõ°¡ ¹× ÀÇ·á ½Ã¼³ Á¢±Ù¼º Çâ»ó
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • Á¤Çü¿Ü°ú Àü¹®°¡¿Í ȯÀÚµéÀÇ Ã·´Ü °ñÀç»ý ±â¼ú¿¡ ´ëÇÑ Àνİú äÅÃÀÌ Á¦ÇÑÀûÀÓ.
    • »ý»ê ±Ô¸ð È®´ë ¹× °ñÀç»ý ¼ÒÀçÀÇ Ç°Áú ¾ÈÁ¤¼º È®º¸¿¡ ´ëÇÑ °úÁ¦
  • ½ÃÀå ±âȸ
    • »À °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í È¿°úÀûÀÎ Àç»ý Ä¡·áÀÇ Çʿ伺
    • °ñÀç»ý Á¦Ç°ÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ´Â »ýü Àç·áÀÇ ±â¼ú ¹ßÀü
    • ÀÓ»ó¿¡¼­ÀÇ °ñÀç»ý Àç·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡µéÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
  • ½ÃÀå °úÁ¦
    • °ñÀç»ý Àç·á ½ÃÀåÀÇ ³ôÀº ¿øÀÚÀç ºñ¿ë°ú Á¦ÇÑµÈ °¡¿ë¼º
    • °ñÀç»ý ¼ÒÀç¿Í ±âÁ¸ ÀÇ·á±â±âÀÇ ÅëÇÕ¿¡ ´ëÇÑ ±â¼úÀû °úÁ¦ ±Øº¹

Porter's Five Forces : °ñÀç»ý Àç·á ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °ñÀç»ý ¼ÒÀç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °ñÀç»ý Àç·á ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °ñÀç»ý ¼ÒÀç ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

°ñÀç»ý Àç·á ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °ñÀç»ý Àç·á ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °ñÀç»ý Àç·á ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ °ñÀç»ý ¼ÒÀç ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸®´Ù

°ñÀç»ý ¼ÒÀç ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °ñÀç»ý Àç·á ½ÃÀå : À¯Çüº°

  • °ñÇü¼º ´Ü¹éÁú(BMP)
  • ¼¼Æ÷ ±â¹Ý ¸ÅÆ®¸¯½º
  • Żȸ°ñ ±âÁú(DBM)
  • Àΰø°ñ À̽Ä

Á¦7Àå °ñÀç»ý Àç·á ½ÃÀå : ¼ÒÀ纰

  • ¼¼¶ó¹Í
  • º¹ÇÕÀç·á
  • Æú¸®¸Ó

Á¦8Àå °ñÀç»ý Àç·á ½ÃÀå : ¿ëµµº°

  • µÎ°³¾Ç¾È¸é
  • Ä¡°ú
  • °üÀý Àç°Ç

Á¦9Àå °ñÀç»ý Àç·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ŭ¸®´Ð
  • º´¿ø

Á¦10Àå °ñÀç»ý Àç·á ½ÃÀå ¼ÒÀç Çüź°

  • °Ö
  • °ú¸³
  • ÆÐƼ

Á¦11Àå °ñÀç»ý Àç·á ½ÃÀå : Á¦Ç°º°

  • õ¿¬ ¼ÒÀç
  • ÇÕ¼º ¼ÒÀç

Á¦12Àå ¾Æ¸Þ¸®Ä«ÀÇ °ñÀç»ý Àç·á ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °ñÀç»ý Àç·á ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦14Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °ñÀç»ý Àç·á ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦15Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È
ksm 24.10.24

The Bone Regeneration Material Market was valued at USD 5.61 billion in 2023, expected to reach USD 6.03 billion in 2024, and is projected to grow at a CAGR of 7.72%, to USD 9.45 billion by 2030.

Bone regeneration materials are specialized products designed to support and enhance the natural process of bone healing and regrowth in conditions such as fractures, bone defects, and skeletal abnormalities. These materials are necessary due to the growing prevalence of orthopedic disorders, an aging population prone to bone-related conditions, and advancements in dental and orthopedic surgeries that demand effective bone graft solutions. Applications span dental implants, spinal fusion, joint reconstruction, trauma, and orthopedics, serving end-users ranging from hospitals and clinics to research organizations. The market is driven by several key factors, including technological advancements in biomaterials, increasing funding and investments in R&D, and the rising adoption of synthetic and biocompatible materials. Furthermore, government initiatives promoting healthcare infrastructure and favorable reimbursement policies are fostering growth. Cutting-edge opportunities lie in the development of bioactive materials and 3D-printed scaffolds, which promise personalized medicine solutions and enhanced regeneration capabilities. However, challenges such as high costs, stringent regulatory approvals, and limited awareness, especially in emerging regions, can impede market expansion. Additionally, the risk of immune reactions and infection associated with bone graft materials raises concerns. To overcome these hurdles, firms should focus on cost-effective manufacturing processes and streamline regulatory pathways. Innovations should target nanotechnology to improve material properties, creating multifunctional scaffolds with superior mechanical strength and bioactivity. Collaborative efforts between academia, industry, and healthcare providers can also drive breakthroughs in tissue engineering. The bone regeneration material market is dynamic, with potential for growth amid these challenges, necessitating strategic planning and technological foresight to harness emerging opportunities and enhance product portfolios for sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.61 billion
Estimated Year [2024] USD 6.03 billion
Forecast Year [2030] USD 9.45 billion
CAGR (%) 7.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Regeneration Material Market

The Bone Regeneration Material Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness about advanced bone healing treatments among patients and healthcare providers
    • Emergence of innovative biomaterials and synthetic bone graft products
    • Collaborations between research institutes and key industry players for product development
    • Rising healthcare expenditure and better access to medical facilities
  • Market Restraints
    • Limited awareness and adoption of advanced bone regeneration technologies among orthopedic professionals and patients
    • Challenges in scaling up production and ensuring consistency in quality of bone regeneration materials
  • Market Opportunities
    • Rising prevalence of bone-related disorders and the need for effective regenerative therapies
    • Technological advancements in biomaterials driving innovation in bone regeneration products
    • Growing awareness among healthcare professionals about the benefits of bone regeneration materials in clinical practices
  • Market Challenges
    • High cost and limited availability of raw materials for bone regeneration materials market
    • Overcoming technical challenges in integrating bone regeneration materials with existing medical devices

Porter's Five Forces: A Strategic Tool for Navigating the Bone Regeneration Material Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Regeneration Material Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Regeneration Material Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Regeneration Material Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Regeneration Material Market

A detailed market share analysis in the Bone Regeneration Material Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Regeneration Material Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Regeneration Material Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Regeneration Material Market

A strategic analysis of the Bone Regeneration Material Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Regeneration Material Market, highlighting leading vendors and their innovative profiles. These include Bioventus, BONESUPPORT AB, Botiss Biomaterials GmbH, Collagen Matrix, Inc., Dentsply Sirona, DePuy Synthes, Geistlich Pharma, Global Biomedica, Integra LifeSciences, Medtronic, MicroPort Orthopedics Inc., NovaBone Products, NuVasive Inc., Orthofix Medical Inc., OssDsign AB, RTI Surgical, SeaSpine Holdings Corporation, Straumann Group, Stryker Corporation, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Bone Regeneration Material Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bone Morphogenetic Proteins (BMPs), Cell-Based Matrices, Demineralized Bone Matrix (DBM), and Synthetic Bone Grafts.
  • Based on Material, market is studied across Ceramics, Composites, and Polymer.
  • Based on Application, market is studied across Craniomaxillofacial, Dental, and Joint Reconstruction.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Material Form, market is studied across Gel, Granules, and Putty.
  • Based on Product, market is studied across Natural Materials and Synthetic Materials.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness about advanced bone healing treatments among patients and healthcare providers
      • 5.1.1.2. Emergence of innovative biomaterials and synthetic bone graft products
      • 5.1.1.3. Collaborations between research institutes and key industry players for product development
      • 5.1.1.4. Rising healthcare expenditure and better access to medical facilities
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and adoption of advanced bone regeneration technologies among orthopedic professionals and patients
      • 5.1.2.2. Challenges in scaling up production and ensuring consistency in quality of bone regeneration materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising prevalence of bone-related disorders and the need for effective regenerative therapies
      • 5.1.3.2. Technological advancements in biomaterials driving innovation in bone regeneration products
      • 5.1.3.3. Growing awareness among healthcare professionals about the benefits of bone regeneration materials in clinical practices
    • 5.1.4. Challenges
      • 5.1.4.1. High cost and limited availability of raw materials for bone regeneration materials market
      • 5.1.4.2. Overcoming technical challenges in integrating bone regeneration materials with existing medical devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Regeneration Material Market, by Type

  • 6.1. Introduction
  • 6.2. Bone Morphogenetic Proteins (BMPs)
  • 6.3. Cell-Based Matrices
  • 6.4. Demineralized Bone Matrix (DBM)
  • 6.5. Synthetic Bone Grafts

7. Bone Regeneration Material Market, by Material

  • 7.1. Introduction
  • 7.2. Ceramics
  • 7.3. Composites
  • 7.4. Polymer

8. Bone Regeneration Material Market, by Application

  • 8.1. Introduction
  • 8.2. Craniomaxillofacial
  • 8.3. Dental
  • 8.4. Joint Reconstruction

9. Bone Regeneration Material Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Clinics
  • 9.4. Hospitals

10. Bone Regeneration Material Market, by Material Form

  • 10.1. Introduction
  • 10.2. Gel
  • 10.3. Granules
  • 10.4. Putty

11. Bone Regeneration Material Market, by Product

  • 11.1. Introduction
  • 11.2. Natural Materials
  • 11.3. Synthetic Materials

12. Americas Bone Regeneration Material Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Bone Regeneration Material Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Bone Regeneration Material Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bioventus
  • 2. BONESUPPORT AB
  • 3. Botiss Biomaterials GmbH
  • 4. Collagen Matrix, Inc.
  • 5. Dentsply Sirona
  • 6. DePuy Synthes
  • 7. Geistlich Pharma
  • 8. Global Biomedica
  • 9. Integra LifeSciences
  • 10. Medtronic
  • 11. MicroPort Orthopedics Inc.
  • 12. NovaBone Products
  • 13. NuVasive Inc.
  • 14. Orthofix Medical Inc.
  • 15. OssDsign AB
  • 16. RTI Surgical
  • 17. SeaSpine Holdings Corporation
  • 18. Straumann Group
  • 19. Stryker Corporation
  • 20. Zimmer Biomet
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦